Acadia Pharmaceuticals Stock Trading Halted Today
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- US stocks close down as oil spikes 12%, job market weakens
- U.S. nonfarm payroll employment unexpectedly falls in February
- Oracle stock falls on report of scrapped Texas data center plans
- Kuwait cuts oil output as storage fills up
- Boeing reportedly nearing 500-aircraft deal with China ahead of Trump visit
- After-hours movers: Marvell, Samsara, GAP, Cooper Cos.
- After-hours movers: Broadcom, StubHub, Cracker Barrel, Grocery Outlet, Veeva Systems and more
- After-hours movers: Moderna, CrowdStrike, Ross Stores, Box and more
- After-hours movers: MongoDB, Credo, SoFi Technologies and more
- After-hours movers: Dell, Block, CoreWeave, Autodesk, MARA and more
Goldman Sachs on Acadia Pharmaceuticals (ACAD): 'We expect the stock to move lower on Tuesday given the results of the vote'
June 21, 2022 10:18 AM UTCGoldman Sachs analyst Salveen Richter reiterated a Neutral rating and $20.00 price target on Acadia Pharmaceuticals (NASDAQ: ACAD)
The analyst comments "The FDA's Psychopharmacologic Drugs Advisory Committee (PDAC) voted against pimavanserin (Nuplazid) as an effective treatment for hallucinations and delusions in Alzheimer's disease psychosis (ADP) (Vote: 9 No/3 Yes), and recommended... More
Acadia Pharma (ACAD) Resume Trading, Down 32%
June 21, 2022 7:11 AM UTCAcadia Pharma (NASDAQ: ACAD) Resume Trading, Down 32%
... More